The consequences of anemia, defined as low hemoglobin (Hb) concentration, are significant and many, including poor maternal and perinatal outcomes such as maternal mortality, low birth weight and ...

HemoCue develops point-of-care testing systems like hemoglobin, glucose and others worldwide. The company believes that, in addition to its earlier divestment of OralDNA Labs salivary-diagnostics ...

As per its plan to sell the HemoCue diagnostics products business, Quest Diagnostics (DGX), recently completed the divesture of the same. The company announced that Radiometer Medical ApS purchased ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products ...

In February 2013, Quest Diagnostics announced it had entered into a definitive agreement to sell HemoCue to Radiometer, with plans to use the proceeds to repurchase approximately $300 million of Quest ...

Radiometer Limited, a leading provider of technologically advanced acute care testing solutions, is pleased to announce that following its recent acquisition of HemoCue, the Company will be offering ...

Co announces it has acquired HemoCue, a Swedish co specializing in near patient testing, also known as point-of- care testing, from the private equity firm E.Q.T II B.V. in a cash transaction valued ...

Paid and presented by Hemocue. It is estimated that anaemia affects 42% of children under the age of five and if left untreated, can affect cognitive and physical development. Early detection is vital ...